$126 Million is the total value of Fiera Capital (Europe) Ltd.'s 69 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 30.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIDU | Buy | BAIDU INCspon adr rep a | $22,439,000 | +29.2% | 119,862 | +4.9% | 17.83% | +35.6% |
| ITUB | Buy | ITAU UNBANCO HLDG SAspon adr rep pfd | $19,903,000 | -1.0% | 1,385,545 | +2.4% | 15.81% | +3.8% |
| PBRA | Buy | PETROLEO BRASILEIRO SA PETROsp adr non vtg | $10,551,000 | +26.2% | 675,307 | +11.8% | 8.38% | +32.4% |
| ABEV | Buy | AMBEV SAsponsored adr | $9,312,000 | -2.5% | 1,323,601 | +2.8% | 7.40% | +2.3% |
| FMX | Sell | FOMENTO ECONOMICO MEXICAN Sspon adr units | $6,376,000 | -34.9% | 68,043 | -35.3% | 5.07% | -31.7% |
| BBD | Buy | BANCO BRADESCO S Asp adr pfd new | $6,363,000 | +26.9% | 438,389 | +19.6% | 5.06% | +33.2% |
| EDU | Sell | NEW ORIENTAL ED & TECH GRP Ispon adr | $6,002,000 | -23.8% | 226,974 | -15.3% | 4.77% | -20.1% |
| VALE | Sell | VALE S Aadr | $5,495,000 | -55.6% | 415,197 | -53.6% | 4.37% | -53.4% |
| TV | Buy | GRUPO TELEVISA SAspon adr rep ord | $5,309,000 | +9.2% | 155,004 | +6.2% | 4.22% | +14.6% |
| BAP | Sell | CREDICORP LTD | $4,778,000 | +9.5% | 30,773 | -3.1% | 3.80% | +14.8% |
| BRFS | Buy | BRF SAsponsored adr | $4,587,000 | +35.6% | 189,114 | +11.5% | 3.64% | +42.2% |
| JD | New | JD COM INCspon adr cl a | $4,133,000 | – | 145,141 | +100.0% | 3.28% | – |
| TAL | New | TAL ED GROUP | $3,645,000 | – | 132,505 | +100.0% | 2.90% | – |
| CPA | Buy | COPA HOLDINGS SAcl a | $3,343,000 | +3.1% | 23,479 | +15.8% | 2.66% | +8.2% |
| GRAM | Buy | GRANA Y MONTERO S A Asponsored adr | $2,929,000 | +12.3% | 162,390 | +7.6% | 2.33% | +17.8% |
| UGP | New | ULTRAPAR PARTICIPACOES S A | $2,116,000 | – | 89,622 | +100.0% | 1.68% | – |
| AVHOQ | AVIANCA HLDGS SAspon adr rep pfd | $1,615,000 | -5.3% | 100,532 | 0.0% | 1.28% | -0.6% | |
| JNJ | Buy | JOHNSON & JOHNSON | $657,000 | +9.1% | 6,279 | +2.5% | 0.52% | +14.5% |
| CZZ | Buy | COSAN LTD | $603,000 | +131.9% | 44,520 | +95.4% | 0.48% | +143.1% |
| PBR | Buy | PETRO BRASILEIRO SA PETROsponsored adr | $598,000 | +23.3% | 40,833 | +10.6% | 0.48% | +29.4% |
| PFE | Sell | PFIZER INC | $550,000 | -7.7% | 18,533 | -0.1% | 0.44% | -3.1% |
| MRK | MERCK & CO INC | $384,000 | +1.6% | 6,649 | 0.0% | 0.30% | +6.6% | |
| ABBV | Buy | ABBVIE INC | $301,000 | +47.5% | 5,332 | +34.5% | 0.24% | +54.2% |
| GILD | Buy | GILEAD SCIENCES INC | $242,000 | +36.7% | 2,910 | +16.3% | 0.19% | +43.3% |
| AGN | Sell | ALLERGAN INC | $241,000 | +3.0% | 1,420 | -24.9% | 0.19% | +7.9% |
| OREX | Buy | OREXIGEN THERAPEUTICS INC | $217,000 | +19.2% | 35,200 | +24.4% | 0.17% | +24.6% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $214,000 | +8.1% | 4,427 | +15.8% | 0.17% | +13.3% |
| MYL | Buy | MYLAN INC | $209,000 | +22.9% | 4,080 | +17.1% | 0.17% | +28.7% |
| PODD | INSULET CORP | $193,000 | -16.5% | 4,868 | 0.0% | 0.15% | -12.6% | |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $191,000 | +23.2% | 1,622 | +26.1% | 0.15% | +29.9% |
| MDVN | MEDIVATION INC | $176,000 | +18.9% | 2,294 | 0.0% | 0.14% | +25.0% | |
| MDT | MEDTRONIC INC | $173,000 | +3.6% | 2,718 | 0.0% | 0.14% | +8.7% | |
| FRX | Buy | FOREST LABS INC | $167,000 | +42.7% | 1,685 | +32.8% | 0.13% | +49.4% |
| SNY | SANOFIsponsored adr | $143,000 | +0.7% | 2,700 | 0.0% | 0.11% | +5.6% | |
| TBPH | New | THERAVANCE BIOPHARMA INC | $135,000 | – | 4,340 | +100.0% | 0.11% | – |
| THRX | Buy | THERAVANCE INC | $135,000 | -3.6% | 4,532 | +4.1% | 0.11% | +0.9% |
| AMGN | AMGEN INC | $126,000 | -3.8% | 1,065 | 0.0% | 0.10% | +1.0% | |
| BDX | Buy | BECTON DICKINSON & CO | $124,000 | +51.2% | 1,050 | +50.6% | 0.10% | +59.7% |
| ILMN | Sell | ILLUMINA INC | $121,000 | -14.8% | 682 | -28.4% | 0.10% | -11.1% |
| ABT | Buy | ABBOTT LABS | $117,000 | +56.0% | 2,855 | +47.2% | 0.09% | +63.2% |
| IPXL | New | IMPAX LABORATORIES INC | $86,000 | – | 2,865 | +100.0% | 0.07% | – |
| SLXP | Sell | SALIX PHARMACEUTICALS INC | $84,000 | -23.6% | 681 | -36.2% | 0.07% | -19.3% |
| PCYC | Buy | PHARMACYCLICS INC | $84,000 | +61.5% | 937 | +80.5% | 0.07% | +71.8% |
| BSX | New | BOSTON SCIENTIFIC CORP | $77,000 | – | 6,060 | +100.0% | 0.06% | – |
| BIIB | BIOGEN IDEC INC | $74,000 | +2.8% | 236 | 0.0% | 0.06% | +7.3% | |
| P103PS | NPS PHARMACEUTICALS INC | $62,000 | +10.7% | 1,876 | 0.0% | 0.05% | +16.7% | |
| NSTG | NANOSTRING TECHNOLOGIES INC | $61,000 | -28.2% | 4,081 | 0.0% | 0.05% | -25.0% | |
| CELG | Buy | CELGENE CORP | $60,000 | +22.4% | 696 | +100.0% | 0.05% | +29.7% |
| Q | QUINTILES TRANSNATIO HLDGS I | $52,000 | +6.1% | 973 | 0.0% | 0.04% | +10.8% | |
| CBST | CUBIST PHARMACEUTICALS INC | $43,000 | -4.4% | 612 | 0.0% | 0.03% | 0.0% | |
| INCY | New | INCYTE CORP | $43,000 | – | 769 | +100.0% | 0.03% | – |
| SYK | New | STRYKER CORP | $41,000 | – | 482 | +100.0% | 0.03% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $41,000 | – | 664 | +100.0% | 0.03% | – |
| GHDX | New | GENOMIC HEALTH INC | $41,000 | – | 1,486 | +100.0% | 0.03% | – |
| CVD | Sell | COVANCE INC | $41,000 | -18.0% | 482 | -42.8% | 0.03% | -13.2% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $30,000 | -57.1% | 105 | -54.9% | 0.02% | -54.7% |
| MDCO | MEDICINES CO | $28,000 | +3.7% | 970 | 0.0% | 0.02% | +10.0% | |
| WAT | Exit | WATERS CORP | $0 | – | -315 | -100.0% | -0.03% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -499 | -100.0% | -0.03% | – |
| ARWR | Exit | ARROWHEAD RESH CORP | $0 | – | -3,305 | -100.0% | -0.04% | – |
| GGB | Exit | GERDAU S Asponsored adr rep pfd | $0 | – | -57,556 | -100.0% | -0.28% | – |
| CCU | Exit | COMPANIA CERVECERIAS UNIDASsponsored adr | $0 | – | -329,696 | -100.0% | -5.58% | – |
| CTCM | Exit | CTC MEDIA INC | $0 | – | -856,111 | -100.0% | -5.98% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JD.COM ADR | 16 | Q1 2017 | 18.4% |
| GENOMIC HEALTH INC | 16 | Q1 2017 | 9.1% |
| PFIZER INC | 16 | Q1 2017 | 13.5% |
| FOMENTO ECONOMIC ADR | 16 | Q1 2017 | 5.1% |
| BRISTOL MYERS SQUIBB | 16 | Q1 2017 | 4.8% |
| BECTON DICKINSON | 15 | Q1 2017 | 21.4% |
| AMGEN INC | 14 | Q1 2017 | 9.3% |
| BRASIL FOODS ADR | 14 | Q1 2017 | 8.1% |
| VALE S A | 14 | Q1 2017 | 13.5% |
| PHARMACYCLICS INC | 14 | Q1 2017 | 0.8% |
View Fiera Capital (Europe) Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-13 |
| 13F-NT | 2023-11-02 |
| 13F-NT | 2023-08-08 |
| 13F-NT | 2023-05-09 |
| 13F-NT | 2023-02-13 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-09 |
| 13F-NT | 2022-05-16 |
| 13F-NT | 2022-02-11 |
| 13F-NT | 2021-11-12 |
View Fiera Capital (Europe) Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.